8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
STERIS plc (STE)

STERIS ($STE) filed an 8‑K on Feb 4, 2026 to furnish a press release announcing fiscal 2026 Q3 results for…

Filed with the SEC on · Summarized by InvestorsBot

STERIS ($STE) filed an 8‑K on Feb 4, 2026 to furnish a press release announcing fiscal 2026 Q3 results for the period ended Dec 31, 2025. 📢 #STERIS #earnings

Exhibits attached: Exhibit 99.1 = press release (Feb 4, 2026); Exhibit 104 = Cover Page Interactive XBRL. Signed by J. Adam Zangerle, SVP, General Counsel & Company Secretary. 📝 $STE #SECfiling #medtech

Investors: review Exhibit 99.1 and the Inline XBRL (Exhibit 104) for full Q3 FY2026 financials and disclosures. 🔍 $STE #STERIS #earnings

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from STERIS plc

STERIS ($STE) on Feb 4, 2026 issued a press release with financial results for the quarter ended Dec 31, 2025.

8-K · February 4, 2026